Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-19-061068

Chief Financial Officer gave up 370 shares (to pay taxes)

  • Chief Financial Officer acquired 1,300 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ruffo Frank Chief Financial Officer 2019-12-16 Option exercise +1,300 166,276 D
Ruffo Frank Chief Financial Officer 2019-12-16 Shares withheld for taxes −370 $1.80 $666 165,906 D
Derivatives
Ruffo Frank Chief Financial Officer 2019-12-16 Option exercise · Restricted Stock Units −1,300 1,300 D
Loading xslF345X03/doc4.xml…